Previous close | 5.40 |
Open | 5.40 |
Bid | 2.40 |
Ask | 2.60 |
Strike | 131.00 |
Expiry date | 2024-05-31 |
Day's range | 5.40 - 5.40 |
Contract range | N/A |
Volume | |
Open interest | 14 |
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
Matthew Dolan, Executive Vice President of Strategy and Corporate Development at DexCom Inc (NASDAQ:DXCM), sold 2,423 shares of the company on May 15, 2024.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.